In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation.

Jian Cao,James Campbell,Li Liu,Ralph P Mason,Alexander R Lippert
DOI: https://doi.org/10.1021/acs.analchem.6b01096
IF: 7.4
2016-01-01
Analytical Chemistry
Abstract:Tissue oxygenation is a driving parameter of the tumor microenvironment, and hypoxia can be a prognostic indicator of aggressiveness, metastasis, and poor response to therapy. Here, we report a chemiluminescence imaging (CLI) agent based on the oxygen-dependent reduction of a nitroaromatic spiroadamantane 1,2-dioxetane scaffold. Hypoxia ChemiLuminescent Probe 2 (HyCL-2) responds to nitroreductase with similar to 170-fold increase in luminescence intensity and high selectivity for enzymatic reductase versus other small molecule reductants. HyCL-2 can image exogenous nitroreductase in vitro and in vivo in living mice, and total luminescent intensity is increased by similar to 6-fold under low oxygen conditions. H-yCL-2 is demonstrated to report on tumor oxygenation during an oxygen challenge in H1299 lung tumor xenografts grown in a murine model as independently confirmed using multispectral optoacoustic tomography (MSOT) imaging of hemoglobin oxygenation.
What problem does this paper attempt to address?